Caller 8 through 11: Caller 8: JoeM: There are no

New Post Public Reply Private Reply Replies (1) Message Board
Zolis_onkel
205
Caller 8 through 11:
Caller 8:
JoeM: There are no people paid to work for GNBT to post messages on any message board, be it on Yahoo Message Board or elsewhere.
There are some ex-GNBT employees, who are explicitely named NeilNap, Jamie, ... there is a list of them, who are bashing GNBT
definitely on this YMB and we are planning to go after them and try to sue them for the damage they are doing to GNBT.
Caller 9:
Q: What about the mentioned new dividend that was mentioned in a previous PR.
JoeM: First of all we have to sort out this dividend and pay it out, then we will be looking into the neext potential dividends.
All of the scheduled for this CC got messed up because the CM issue.
Q: Was there anything we have done wrong with them to cause them to breech their contract.
JoeM: No, not at all. All the waivers were signed and they (CM) decided not to adhere to the agreement.
Q: Why can't you just get after them and why do you think that all the other waivers now need to receive the dividend.
JoeM: This is a legal question that I cannot answer and I just have to assume that this is the case right now. We have
to figure this out in the near future.
* we are now having to deal with the consequences, such as the drastically declined share price and that in turn
getting us further away from the Nasdaq uplisting.
* this mess needs to be sorted out and we have find out what we can do to correct all of this.
Q: Final request, please be more precise with your predictions of few days, few weeks/ months.
Caller 10:
# technical question on AltuCell, that I have no clue about! My non-native speaker english is not good enough for that.
CEO of AltuCell: Decided to take the offer by GNBT, because he liked JoeM's vision for the company, with all the stuff related
diabetes and the cooperation with the arizona diabetes clinic and the wound care products. All that seem to represent a
a good fit for what AltuCell stand for.
..... (a lot of technical details given that I was not able to follow).
Technical Expert: within the next 12 to 18 months the human clnical trials on the Type I diabetes cure should start.
Caller 11:
Q: What if you are not able to find legal ramifications for what Creek Mountain has done, what would hold any other waiver
to do the same. What else is there that could hold off the dividend payment in the future?
JoeM: There is not much that I can do or foresee what other criminal activities we will be confronted with in the future.
* Just to make one thing very clear. I do not own GNBT stock and I have nothing to gain in what just recently happend
in regards to Creek Mountain or yet another postponement of the dividend.
* From my own perspective, I cannot even imagine to break a legal document like that. Signing an agreement and then doing
the opposite of what we agreed with, really blows my mind. This is beyond my believe and I am shocked that it happened.
* I do no have a clue as to what else can go wrong or show up that would cause us to react upon.
Q: Interested in what you are doing legally about the YMB bashers?
JoeM: %% telling the story about "Natasha", who got caught and the police showed up at her/his home, and told her that she should
not continue doing, and finally considered "her" not dangerous %%

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 30

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 22

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 30

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 30

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 22

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 25

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Quaker Chemical Experiences 52-Week Low Amid Market Challenges

Updated Category News Views 129

Quaker Chemical Faces Significant Market Challenges In a challenging market climate, Quaker Chemical Corporation (NYSE: KWR) recently saw its stock plummet to a 52-week low of $138.97. This specialty chemical company, renowned for its high-performance process fluids and coatings utilized in metalworking, has undergone considerable struggles over the past year, leading to...

Continue Reading
Aura Minerals Completes Significant Bluestone Acquisition

Updated Category News Views 124

Aura Minerals Completes Acquisition of Bluestone Resources Aura Minerals Inc. (TSX: ORA) has successfully executed its acquisition of Bluestone Resources Inc. (BBSRF) through a strategic arrangement. This transaction signals a notable expansion for Aura as it aims to enhance its precious metals portfolio. Terms of the Acquisition Under the recent agreement, shareholders...

Continue Reading
Revolutionizing Employee Benefits with Cutting-Edge Automation

Updated Category News Views 176

Employee Benefits Marketing Transformation In the landscape of employee benefits, there lies a pressing need for innovation, especially regarding effective communication and marketing engagement. Businessolver, a recognized leader in HR and benefits technology, has taken significant strides with the introduction of its Benefits Communication and Automation Engine. This...

Continue Reading
Understanding the Net Asset Value of Middlefield PCC Today

Updated Category News Views 84

Middlefield Canadian Income PCC Overview Middlefield Canadian Income PCC is a distinct investment option that focuses on providing income opportunities. Established as a protected cell company in Jersey, it adheres to well-defined regulatory standards, adding a layer of security for those who invest in it. Net Asset Value Insights In a recent evaluation, the estimated...

Continue Reading
Tarsus Pharmaceuticals Participates in Healthcare Conference

Updated Category News Views 102

Tarsus Pharmaceuticals Engages in Important Healthcare Conference Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is committed to meeting unmet medical needs through innovative scientific advancements and cutting-edge technology. The company places a strong emphasis on eye care, with the goal of transforming the treatment landscape for patients. Recently, Tarsus announced...

Continue Reading